2026 Federal Total THC Limits: What P.L. 119-37 Means for Hemp Products

If you've been using hemp-derived CBD, Delta-8, or Delta-9 products and you've started hearing about a "hemp ban" coming in November 2026  your concern is valid, and you deserve a straight answer.

One Reddit community captured exactly what thousands of consumers are wondering right now: "I use CBD vape pens for anxiety and pain which ones are going to be compliant after the November 2026 hemp ban?" The poster had already done their homework, understood that new total THC limits were coming, and was worried their formulation would be watered down or changed entirely. The top comment told them to bulk-buy and said nothing would be available outside medical dispensaries. That's not fully accurate  and it's exactly the kind of misinformation filling the void right now.

That thread and the broader anxiety it represents is exactly why we wrote this.

This is the most comprehensive consumer-facing breakdown of P.L. 119-37 published by a hemp brand. No law firm speak. No panic. Just what the law actually says, what it means product by product, and what you need to know before November 12, 2026.

What Is P.L. 119-37 and How Did We Get Here?

P.L. 119-37 is the federal Continuing Appropriations Act that President Trump signed on November 12, 2025 to end a 42-day government shutdown. Inside a 1,500-page spending bill, Congress included Section 781  a single provision that rewrites the federal definition of "hemp" under 7 U.S.C. §1639o and effectively bans most hemp-derived cannabinoid products currently on the market.

This was not a standalone Farm Bill. It was not publicly debated. It passed because it was attached to legislation the government needed to stay open. Rep. Andy Harris (R-MD) inserted the language. Sen. Rand Paul (R-KY) tried to strip it and lost 76–24.

The 2018 Farm Bill legalized hemp by defining it as cannabis containing no more than 0.3% delta-9 THC by dry weight. That definition created an enormous legal gray zone — one that gave rise to delta-8 gummies, hemp-derived delta-9 edibles, THCA flower, HHC vapes, and the broader intoxicating hemp market. Section 781 closes that gray zone. The question  and it is a serious one  is how much of the legitimate wellness CBD market it takes with it.

The Two Changes That Reshape Everything

Change #1: "Total THC" Replaces Delta-9-Only Measurement

Under the 2018 Farm Bill, only delta-9 THC counted toward the 0.3% threshold. Every other form of THC  delta-8, delta-10, THCA, THCP  was invisible to federal law. This is what enabled:

• Delta-8 gummies to exist legally, since delta-8 was never measured
• THCA flower to qualify as hemp despite converting to delta-9 THC when smoked or vaped
• High-dose delta-9 gummies, because a heavy 5-gram gummy at 0.3% dry weight legally contained 15mg of delta-9

P.L. 119-37 changes the measurement to total THC  every THC isomer counted together. The calculation uses the formula: (0.877 × THCA) + delta-9 THC, plus delta-8, delta-10, and any other THC variants. If the combined number exceeds 0.3% on a dry weight basis, the product is no longer legally hemp.

Change #2: A 0.4 Milligram Per-Container Cap on Finished Products

This is the provision most coverage underplays  and it's the more consequential of the two for everyday CBD consumers.

For finished products sold at retail, the law sets a hard limit of 0.4 milligrams of total THC per container. Not per serving. The entire package.

To put that in concrete terms: a standard 30-count bottle of full-spectrum CBD gummies with even trace THC levels typically contains 2–15mg of total THC across the bottle. The legal cap for the entire container is 0.4mg  a gap of 5x to 37x the permitted amount.

Jonathan Miller of the U.S. Hemp Roundtable put it plainly: this cap "would encompass 95% of the hemp extract industry even the vast majority of nonintoxicating CBD products have more than 0.4 milligrams of THC per container."

What the Law Also Bans: Synthesized Cannabinoids

Beyond the THC limits, Section 781 explicitly excludes two additional categories from the definition of hemp:

Cannabinoids not naturally produced by the cannabis plant — targeting HHC (hexahydrocannabinol) and THC-O-acetate, which are laboratory-created compounds with no meaningful natural occurrence in hemp.

Cannabinoids that occur naturally in the plant but were synthesized outside it — aimed directly at commercial delta-8 THC. Almost all commercial delta-8 is produced by chemically converting CBD through acid isomerization in a laboratory setting. The amounts of delta-8 that occur naturally in hemp are too small to extract commercially.

Delta-10, HHC, THCP, and THC-O are all eliminated under this provision — entirely separate from the THC cap.

Product by Product: What Survives and What Doesn't

CBD Isolate (verified zero THC)  Survives. Pure CBD with non-detectable THC across the entire container satisfies the 0.4mg cap. Zero THC means zero exposure under this provision.

Full-Spectrum CBD — Serious risk. Full-spectrum products contain trace THC by design. Even small amounts across a 30-serving bottle typically exceed 0.4mg total. Cornbread Hemp CEO Eric Zipperle stated publicly: "If nothing changes, every product we sell will be illegal — including CBD lotion and oil." President Trump's own executive order acknowledged this problem and directed agencies to find a path to preserve "appropriate full-spectrum CBD products." That statutory fix has not been written into law.

Broad-Spectrum CBD (THC-free) — Better positioned than full-spectrum, but not in the clear. CBD extraction involves processing stages where THC concentrations temporarily exceed legal thresholds before being removed. Legal analysts at Benesch Friedlander concluded "there is no way to make these products and remain compliant" under a strict reading of the intermediate product restrictions. A manufacturing safe harbor from FDA  not yet issued would resolve this.

Delta-8 THC Gummies and Vapes  Banned under two independent provisions. Delta-8 is synthetically produced from CBD and counts toward total THC. Both the synthesis exclusion and the 0.4mg cap eliminate it.

Hemp-Derived Delta-9 THC Gummies — Banned. The per-container cap eliminates the dry-weight percentage loophole entirely. A single standard gummy contains many times the allowed amount for the whole package.

THCA Flower — Banned. THCA is included in the total THC formula. Commercially sold THCA flower typically runs 15–25% THCA  far above the 0.3% total THC threshold.

Delta-10, HHC, THCP, THC-O — All banned, either as non-naturally occurring cannabinoids or under total THC limits.

CBG Products — Likely compliant. Cannabigerol is non-intoxicating and naturally produced by the plant. Full-spectrum CBG products with trace THC face the same 0.4mg container cap issue as CBD, but pure CBG isolate is well-positioned.

Functional Mushrooms (no cannabinoids) — Entirely unaffected. Lion's mane, reishi, cordyceps, and other adaptogenic mushroom products contain no hemp-derived cannabinoids and fall completely outside this law's scope.

Hemp Vape Cartridges — The law explicitly names "cartridge" as a container type. Each cartridge must independently satisfy the 0.4mg cap. CBD-dominant vape formulations with verified non-detectable THC may survive. Any formulation with measurable THC does not.

The Timeline

The 365-day window is the only transition period. There is no grandfather clause for existing inventory, no phase-out for products in transit, and no safe harbor for anything already manufactured.

Bills in Congress that could change this: the Hemp Planting Predictability Act would push the effective date to November 2028. The American Hemp Protection Act (Rep. Mace) would repeal Section 781 entirely. A Senate bill from Wyden and Merkley would replace the ban with a proper regulatory framework  5mg THC per serving, 50mg per container, age-21 minimum. As of April 2026, none have passed.

The Unresolved Question That Changes Everything: FDA's Missing Guidance

The law required FDA to publish, within 90 days of enactment, four critical documents: a complete list of cannabinoids naturally produced by cannabis, a list of all THC-class cannabinoids, a list of cannabinoids with "similar effects" to THC, and guidance defining what counts as a "container."

FDA missed the February 10, 2026 deadline. None of those lists exist.

This matters because the law grants HHS unlimited authority to designate additional cannabinoids as THC-like and sweep them into the 0.4mg combined cap. Whether that list includes CBN, THCV, or even CBD is entirely unknown. The "container" definition  is a bag of 30 gummies one container, or is each individually wrapped piece its own container?  is also unanswered.

The industry cannot fully plan for compliance because the complete scope of the ban is still undefined. That's not a loophole. It's a regulatory failure with a hard deadline attached to it.

What This Means for You Right Now

If you rely on CBD for wellness or medical management: The ban is not yet in effect. Products remain legal to purchase and use through November 12, 2026. Congressional action to delay or modify the law is actively underway. This situation is not settled.

If you're worried your current CBD formulation will change: That concern is legitimate. For brands committed to staying federal-compliant, the path forward runs through THC-free or ultra-low-THC formulations. Responsible brands are already working on this. Any brand that isn't is either betting on Congressional intervention or planning to exit the market.

If you use CBD vapes specifically: The shelf-life point raised in the r/Fibromyalgia thread is accurate  vape cartridges typically have a 6–12 month effective window before terpene degradation affects potency. Bulk-buying is not a durable solution. What matters is whether the brands you trust are actively building compliant formulations, not waiting out the clock.

What will likely still be available after November 2026  assuming no Congressional fix: Pure CBD isolate products, CBG products with verified zero THC, functional mushroom supplements, FDA-approved hemp-derived drugs like Epidiolex, and industrial hemp goods. What will not be available federally: anything with measurable THC, all delta-8 formats, THCA products, full-spectrum CBD as currently formulated, and hemp vapes with any THC content.

The Enforcement Reality

The Congressional Research Service raised significant doubts about broad enforcement, noting that "both FDA and DEA may lack the resources to broadly enforce" the new restrictions drawing a comparison to how federal agencies have largely stepped back from state-legal marijuana markets.